Age and Blood Clotting


Although there are around 20 enzymes in the body which are responsible for creating blood clots, there is only one enzyme, called plasmin, which is responsible for dissolving clots. As we age though, the production of plasmin slows down and the body is unable to dissolve clots as easily. In addition to a decrease in plasmin production, aging patients also experience an increase in fibrinogen levels. When the levels of fibrinogen increase, platelet aggregation also increases along with an increase in blood clots throughout the body.40 Of course, this means that the chance of stroke and heart attack increases as well. In fact, abnormal levels of fibrinogen are more closely correlated with stokes and heart attacks than is high cholesterol.

Aging patients, who are at an increased risk of developing thrombus, should consider adding nattokinase to their supplement regimen since research on this enzyme has proven that it has an unmatched ability to control such natural imbalances in patients in order to give them a healthier life. Moreover, nattokinase has no side effects and the beneficial effects can be prolonged, unlike many drugs. Nattokinase can eliminate fibrin, which forms clots within the vessels and at the same time activates the body’s production of the enzyme pro-urokinase.

Nattokinase is a fibrinolytic (fibrin dissolving) enzyme, which has been clinically shown to reduce the formation and incidence of blood clots.  Fibrinolytic enzymes, such as nattokinase, act via the immunological system as biological response modifiers. Nattokinase is essentially carried by anti-proteinases, such as alpha-2 macroglobulin 79 and does not bypass the “checks and balances” system that maintains coagulation and plasminogen homeostasis within the body. Additionally, alpha-2 macroglobulin functions as a form of safety inhibitor and interacts with various proteolytic enzymes as an inhibitory system that prevents bleeding abnormalities.

In summary nattokinase, can be taken to support healthy blood circulation and normal clot formation.  Unlike blood thinning drugs including asprin, nattokinase is safe, and does not produce an incidence of internal bleeding.